Public Health England. Public health control and management of diphtheria (in England and Wales). Mar 2015 [internet publication].
American Academy of Pediatrics. Red Book Online: Diphtheria. 2015:325-329. http://aapredbook.aappublications.org/ (last accessed 18 March 2017).
1. Centers for Disease Control and Prevention. Manual for the surveillance of vaccine-preventable diseases. Chapter 1: diphtheria. Mar 2018 [internet publication].
2. Lee PL, Lemos B, O'Brien SH, et al. Cutaneous diphtheroid infection and review of other cutaneous Gram-positive Bacillus infections. Cutis. 2007 May;79(5):371-7.
3. Belsey MA, LeBlanc DR. Skin infections and the epidemiology of diphtheria: acquisition and persistence of C diphtheriae infections. Am J Epidemiol. 1975 Aug;102(2):179-84.
4. Afghani B, Stutman HR. Bacterial arthritis caused by Corynebacterium diphtheriae. Pediatr Infect Dis J. 1993 Oct;12(10):881-2.
5. Vitek CR, Bogatyreva EY, Wharton M. Diphtheria surveillance and control in the former Soviet Union and the newly independent states. J Infect Dis. 2000 Feb;181 Suppl 1:S23-6.
6. Galazka A. The changing epidemiology of diphtheria in the vaccine era. J Infect Dis. 2000 Feb;181 Suppl 1:S2-9.
7. Vitek CR, Wharton M. Diphtheria in the former Soviet Union: reemergence of a pandemic disease. Emerg Infect Dis. 1998 Oct-Dec;4(4):539-50.
8. Tiwari TS. Diptheria. In: Centers for Disease Control and Prevention. CDC Yellow Book 2018: health information for international travel. Chapter 3 - infectious diseases related to travel. New York, NY: Oxford University Press; 2017.
9. World Health Organization. Diphtheria vaccine: WHO position paper - August 2017. Wkly Epidemiol Rec. 2017 Aug 4;92(31):417-35.
10. World Health Organization. Diphtheria - Yemen. Disease outbreak news 22 December 2017. Dec 2017 [internet publication].
11. World Health Organization. Diphtheria - Cox's Bazar in Bangladesh. Disease outbreak news 13 December 2017. Dec 2017 [internet publication].
12. Centers for Disease Control and Prevention. Diphtheria: clinicians. Jan 2016 [internet publication].
13. Liang JL, Tiwari T, Moro P, et al. Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2018;67(2):1-44.
14. Centers for Disease Control and Prevention; Hamborsky J, Kroger A, Wolfe S, eds. Epidemiology and prevention of vaccine-preventable diseases. 13th ed. Washington D.C: Public Health Foundation; 2015.
15. Murphy JR. Corynebacterium diphtheriae. In: Baron S, ed. Medical microbiology. 4th ed. Galveston, TX: University of Texas Medical Branch at Galveston; 1996.
16. American Academy of Pediatrics Committee on Infectious Diseases. Diphtheria. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, eds. Red Book: 2018 report of the Committee on Infectious Diseases. 31st ed. Itasca, IL: American Academy of Pediatrics; 2018:319-23.
17. Centers for Disease Control and Prevention. Respiratory diphtheria caused by Corynebacterium ulcerans: Terre Haute, Indiana, 1996. MMWR Morb Mortal Wkly Rep. 1997 Apr 18;46(15):330-2.
18. Robinson CL, Bernstein H, Romero JR, et al. Advisory Committee on Immunization Practices recommended immunization schedule for children and adolescents aged 18 years or younger - United States, 2019. MMWR Morb Mortal Wkly Rep. 2019 Feb 8;68(5):112-114.
19. Centers for Disease Control and Prevention (CDC). Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine and guidance for use as a booster dose. MMWR Morb Mortal Wkly Rep. 2008 Oct 3;57(39):1078-9.
20. Halperin SA, Tapiero B, Diaz-Mitoma F, et al. Safety and immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 3, 4, and 12-14 months of age. Vaccine. 2009 Apr 28;27(19):2540-7.
21. Department of Health. Diphtheria: the green book, chapter 15. Apr 2013 [internet publication].
22. Guo B, Page A, Wang H, et al. Systematic review of reporting rates of adverse events following immunization: An international comparison of post-marketing surveillance programs with reference to China. Vaccine. 2013 Jan 11;31(4):603-17.
23. Kim DK, Hunter P. Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older - United States, 2019. MMWR Morb Mortal Wkly Rep. 2019 Feb 8;68(5):115-118.
24. ACOG Committee on Obstetric Practice, Immunization and Emerging Infections Expert Work Group. Committee opinion no. 718. Update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination. Obstet Gynecol. 2017 Sep;130(3):e153-7.
25. Sukumaran L, McCarthy NL, Kharbanda EO, et al. Infant hospitalizations and mortality after maternal vaccination. Pediatrics. 2018;141(3):e20173310.
26. Stephen Buescher. Diphtheria. In: Behrman RE, Kliegman R, Jenson HB, eds. Nelson textbook of pediatrics. 17th ed. Philadelphia, PA: WB Saunders Co; 2004:886-9.
27. Favorova LA. The risk of infection in droplet infections. The influence of overcrowding and prolonged contact on transmission of the diphtheria pathogen. J Hyg Epidemiol Microbiol Immunol. 1969;13(1):73-82.
28. Public Health England. Public health control and management of diphtheria (in England and Wales). Mar 2015 [internet publication].
29. Tejpratap SP, Tiwari MD. Manual for the surveillance of vaccine-preventable diseases (5th ed): Diphtheria. August 2011. http://www.cdc.gov (last accessed 18 March 2017).
30. American Academy of Pediatrics. Red Book Online: Diphtheria. 2015:325-329. http://aapredbook.aappublications.org/ (last accessed 18 March 2017).
31. Centers for Disease Control and Prevention. Diphtheria. January 2016. http://www.cdc.gov/diphtheria/clinicians.html/ (last accessed 18 March 2017).
32. Centers for Disease Control and Prevention. Use of diphtheria antitoxin (DAT) for suspected diphtheria cases. Sep 2016 [internet publication].
33. Logina I, Donaghy M. Diphtheritic polyneuropathy: a clinical study and comparison with Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry. 1999 Oct;67(4):433-8.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台